[
    [
        {
            "time": "",
            "original_text": "泛生子与华大基因怎么样？在抗癌筛查检测领域究竟谁才领路人",
            "features": {
                "keywords": [
                    "泛生子",
                    "华大基因",
                    "抗癌筛查",
                    "检测领域",
                    "领路人"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "泛生子与华大基因怎么样？在抗癌筛查检测领域究竟谁才领路人",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]